| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $24.2M | -4.5% | +3.0% |
| Cost of Revenue | $5.3M | -3.5% | -13.2% |
| Gross Profit | $18.9M | -4.8% | +8.7% |
| R&D Expense | $2.0M | -18.5% | +106.7% |
| SG&A Expense | $21.1M | +76.0% | +119.5% |
| Operating Income | -$7.7M | -754.8% | -512.7% |
| Pre-tax Income | -$7.6M |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $222.1M | -3.7% | -11.2% |
| Accounts Receivable | $4.4M | +0.3% | -3.2% |
| Current Assets | $272.6M | +2.0% | -7.5% |
| Total Assets | $287.7M | -3.0% | -27.3% |
| Current Liabilities | $48.8M | +3.4% | +55.9% |
| Long-term Debt |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$8.6M | — | — |
| Capital Expenditures | $56K | — | — |
| Investing Cash Flow | -$911K | — | — |
| Financing Cash Flow | -$10.6M | — | — |
| Free Cash Flow | -$8.7M | — | — |
| -780.9% |
| -456.9% |
| Income Tax | -$16K | -120.0% | -102.3% |
| Net Income | -$7.6M | -832.0% | -626.7% |
| EPS (Basic) | -$0.06 | -700.0% | -700.0% |
| EPS (Diluted) | -$0.06 | -700.0% | -700.0% |
| $134.4M |
| -1.3% |
| -5.1% |
| Total Liabilities | $214.8M | -1.3% | +22.6% |
| Stockholders' Equity | $72.8M | -7.8% | -67.0% |